| Dr Wilson Wing Kong Tso, DDS | |
|
1063 Geneva Ave, San Francisco, CA 94112 | |
| (415) 239-6008 | |
| Not Available |
| Full Name | Dr Wilson Wing Kong Tso |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 1063 Geneva Ave, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154473320 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 40505 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wilson Wing Kong Tso, DDS 1063 Geneva Ave, San Francisco, CA 94112 Ph: (415) 239-6008 | Dr Wilson Wing Kong Tso, DDS 1063 Geneva Ave, San Francisco, CA 94112 Ph: (415) 239-6008 |
News Archive
Exposure during early pregnancy to some phthalates—man-made chemicals commonly found in household plastics, food and personal care products—can have adverse impacts on developing fetuses, according to a new study led by Dr. Sheela Sathyanarayana, a pediatric environmental health specialist at Seattle Children's Research Institute and associate professor at the University of Washington.
Trillium Therapeutics Inc., a privately-held biopharmaceutical company, announced today that it has raised $1 million from a new undisclosed investor. The funds will be used to advance its lead program, TTI-1612, into clinical trials for the treatment of interstitial cystitis, also known as bladder pain syndrome. The first trial is projected to start in the second half of this year.
With growing interest in its potential health benefits and new legislation favoring legalization in more states, cannabis use is becoming more common among older adults.
A multidisciplinary research group of the Universitat Politècnica de Catalunya · BarcelonaTech (UPC) and the Germans Trias i Pujol Research Institute (IGTP) have analysed the diagnostic delay between the development of symptoms of COVID-19 and the registration of a positive case in ten countries in the European Union.
Pfizer Inc. today reported the top-line results of an international Phase III clinical trial which compared the combination of VFEND (voriconazole) and ERAXISTM (anidulafungin) to VFEND monotherapy for primary therapy of invasive aspergillosis, a life-threatening invasive fungal infection that can develop as a complication in patients with compromised immune systems.
› Verified 8 days ago
Dr. Cuong Chi Ho, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 156 W Portal Ave # C, San Francisco, CA 94127 Phone: 415-564-2200 Fax: 415-520-6737 | |
Dr. Laila Kafi, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2827 Franklin St, San Francisco, CA 94123 Phone: 415-776-1900 Fax: 415-776-5504 | |
Dr. Ephraim W Aklilu, Dentist Medicare: Not Enrolled in Medicare Practice Location: 58 W Portal Ave # 106, San Francisco, CA 94127 Phone: 510-914-6903 | |
Dr. Kapil Deepak Kirpekar, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2494 Mission St, San Francisco, CA 94110 Phone: 415-873-8225 | |
Dr. Anh T Nguyen, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2295 California St Apt 37, San Francisco, CA 94115 Phone: 408-209-4711 | |
Alireza Khoshvaghti, DDS Dentist Medicare: Medicare Enrolled Practice Location: 220 Montgomery St Ste 483, San Francisco, CA 94104 Phone: 415-398-6344 | |
Joseph Yang, MD, DMD, MBE Dentist Medicare: Medicare Enrolled Practice Location: 99 W Portal Ave, San Francisco, CA 94127 Phone: 415-661-6006 |